Publication Information

{'id': 'https://openalex.org/W3030897071', 'doi': 'https://doi.org/10.3877/cma.j.issn.1674-0785.2020.01.012', 'title': 'Long-acting versus standard non-ergot dopamine agonists in treatment of Parkinson′s disease: a Meta-analysis of randomized controlled trails', 'display_name': 'Long-acting versus standard non-ergot dopamine agonists in treatment of Parkinson′s disease: a Meta-analysis of randomized controlled trails', 'publication_year': 2020, 'publication_date': '2020-01-15', 'ids': {'openalex': 'https://openalex.org/W3030897071', 'doi': 'https://doi.org/10.3877/cma.j.issn.1674-0785.2020.01.012', 'mag': '3030897071'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://rs.yiigle.com/CN119147202001/1186768.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306506088', 'display_name': 'Chin J Clinicians(Electronic Edition)', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5106665107', 'display_name': 'Changqing Zhou', 'orcid': 'https://orcid.org/0000-0002-7269-6380'}, 'institutions': [{'id': 'https://openalex.org/I4210129419', 'display_name': "People's Hospital of Bishan District", 'ror': 'https://ror.org/03p184w47', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210129419']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Changqing Zhou', 'raw_affiliation_strings': ['Department of Neurology, People′s Hospital of Bishan District, Chongqing 402760, China'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology, People′s Hospital of Bishan District, Chongqing 402760, China', 'institution_ids': ['https://openalex.org/I4210129419']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055543975', 'display_name': 'Chang Gao', 'orcid': 'https://orcid.org/0000-0003-3597-1360'}, 'institutions': [{'id': 'https://openalex.org/I4210129419', 'display_name': "People's Hospital of Bishan District", 'ror': 'https://ror.org/03p184w47', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210129419']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Chang Gao', 'raw_affiliation_strings': ['Department of Neurology, People′s Hospital of Bishan District, Chongqing 402760, China'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology, People′s Hospital of Bishan District, Chongqing 402760, China', 'institution_ids': ['https://openalex.org/I4210129419']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5111457829', 'display_name': 'Guo‐Guang Peng', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I87780372', 'display_name': 'Chongqing Medical University', 'ror': 'https://ror.org/017z00e58', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I87780372']}, {'id': 'https://openalex.org/I4210129459', 'display_name': 'First Affiliated Hospital of Chongqing Medical University', 'ror': 'https://ror.org/033vnzz93', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210129459']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Guoguang Peng', 'raw_affiliation_strings': ['Department of Neurology; The First Affiliated Hospital of Chongqing Medical University; Chongqing 400016 China'], 'affiliations': [{'raw_affiliation_string': 'Department of Neurology; The First Affiliated Hospital of Chongqing Medical University; Chongqing 400016 China', 'institution_ids': ['https://openalex.org/I87780372', 'https://openalex.org/I4210129459']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 60}, 'biblio': {'volume': '14', 'issue': '01', 'first_page': '52', 'last_page': '61'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10085', 'display_name': "Parkinson's Disease Mechanisms and Treatments", 'score': 0.9979, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10085', 'display_name': "Parkinson's Disease Mechanisms and Treatments", 'score': 0.9979, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11274', 'display_name': 'Botulinum Toxin and Related Neurological Disorders', 'score': 0.9842, 'subfield': {'id': 'https://openalex.org/subfields/2728', 'display_name': 'Neurology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/ropinirole', 'display_name': 'Ropinirole', 'score': 0.81912553}, {'id': 'https://openalex.org/keywords/tolerability', 'display_name': 'Tolerability', 'score': 0.7953694}, {'id': 'https://openalex.org/keywords/pramipexole', 'display_name': 'Pramipexole', 'score': 0.55878574}], 'concepts': [{'id': 'https://openalex.org/C2777453868', 'wikidata': 'https://www.wikidata.org/wiki/Q420590', 'display_name': 'Ropinirole', 'level': 5, 'score': 0.81912553}, {'id': 'https://openalex.org/C2778375690', 'wikidata': 'https://www.wikidata.org/wiki/Q7814214', 'display_name': 'Tolerability', 'level': 3, 'score': 0.7953694}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.74597293}, {'id': 'https://openalex.org/C95190672', 'wikidata': 'https://www.wikidata.org/wiki/Q815382', 'display_name': 'Meta-analysis', 'level': 2, 'score': 0.71608156}, {'id': 'https://openalex.org/C82789193', 'wikidata': 'https://www.wikidata.org/wiki/Q2142611', 'display_name': 'Relative risk', 'level': 3, 'score': 0.69635534}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.67610365}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.62176853}, {'id': 'https://openalex.org/C2776478404', 'wikidata': 'https://www.wikidata.org/wiki/Q1105187', 'display_name': 'Cochrane Library', 'level': 3, 'score': 0.6066853}, {'id': 'https://openalex.org/C2779989193', 'wikidata': 'https://www.wikidata.org/wiki/Q421304', 'display_name': 'Pramipexole', 'level': 4, 'score': 0.55878574}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5440438}, {'id': 'https://openalex.org/C2779734285', 'wikidata': 'https://www.wikidata.org/wiki/Q11085', 'display_name': "Parkinson's disease", 'level': 3, 'score': 0.513734}, {'id': 'https://openalex.org/C44249647', 'wikidata': 'https://www.wikidata.org/wiki/Q208498', 'display_name': 'Confidence interval', 'level': 2, 'score': 0.2623547}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.2500144}, {'id': 'https://openalex.org/C2780304432', 'wikidata': 'https://www.wikidata.org/wiki/Q300989', 'display_name': 'Levodopa', 'level': 4, 'score': 0.06241086}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://rs.yiigle.com/CN119147202001/1186768.htm', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306506088', 'display_name': 'Chin J Clinicians(Electronic Edition)', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.79}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3211902111', 'https://openalex.org/W3209149131', 'https://openalex.org/W3161082569', 'https://openalex.org/W3119710654', 'https://openalex.org/W3046669787', 'https://openalex.org/W3032340400', 'https://openalex.org/W3031019775', 'https://openalex.org/W2963274141', 'https://openalex.org/W2944231693', 'https://openalex.org/W2888697569', 'https://openalex.org/W2381176958', 'https://openalex.org/W2379828444', 'https://openalex.org/W2368685000', 'https://openalex.org/W2355866969', 'https://openalex.org/W2352827109', 'https://openalex.org/W2342389553', 'https://openalex.org/W2166618774', 'https://openalex.org/W2160378517', 'https://openalex.org/W2117018746', 'https://openalex.org/W2112139477'], 'abstract_inverted_index': {'Objective\r\nTo': [0], 'evaluate': [1], 'the': [2, 16, 72, 92, 143, 152, 185], 'efficacy,': [3, 180], 'tolerability,': [4, 181], 'and': [5, 35, 52, 65, 113, 146, 161, 182], 'safety': [6, 183], 'of': [7, 18, 25, 37, 86, 154, 187], 'long-acting': [8, 95, 172], 'versus': [9], 'standard': [10, 93, 177], 'non-ergot': [11], 'dopamine': [12, 200], 'agonists': [13], '(NEDAs)': [14], 'in': [15, 81, 100, 125, 151, 179, 184], 'treatment': [17, 186], 'Parkinson′s': [19, 188], 'disease': [20], 'by': [21], 'performing': [22], 'a': [23], 'Meta-analysis': [24, 87, 169], 'randomized': [26], 'controlled': [27], 'trials': [28], '(RCTs).\r\n\r\n\r\nMethods\r\nThe': [29], 'PubMed,': [30], 'EMBASE,': [31], 'Cochrane': [32], 'Library': [33], 'databases,': [34], 'Web': [36], 'Knowledge': [38], 'were': [39, 58, 68, 79], 'searched': [40], 'up': [41], 'to': [42, 70, 135, 176], 'August': [43], '15,': [44], '2019.': [45], 'The': [46, 84], 'pooled': [47], 'weighted': [48], 'mean': [49], 'difference': [50], '(WMD)': [51], 'relative': [53], 'risk': [54], '(RR)': [55], 'with': [56, 91], '95%CI': [57], 'calculated.': [59], 'Review': [60], 'Manager': [61], 'software': [62], 'version': [63], '5.3': [64], 'Stata': [66], '12.0': [67], 'used': [69], 'analyze': [71], 'data.\r\n\r\n\r\nResults\r\nEleven': [73], 'large-scale': [74], 'RCTs,': [75], 'involving': [76], '3280': [77], 'patients,': [78], 'included': [80], 'this': [82], 'Meta-analysis.': [83], 'results': [85], 'showed': [88], 'that': [89, 171], 'compared': [90], 'NEDAs,': [94], 'NEDAs': [96, 173, 178], 'exhibited': [97], 'similar': [98, 175], 'improvements': [99], 'UPDRSⅡ': [101], 'score': [102, 108, 116], '(WMD=-0.15,': [103], '95%': [104, 110, 118, 129, 139, 158, 166], 'CI:': [105, 111, 119, 130, 140, 159, 167], '-0.63-0.33),': [106], 'UPDRSⅢ': [107], '(WMD=0.04,': [109], '-0.24-0.33)': [112], 'UPDRSⅡ+': [114], 'Ⅲ': [115], '(WMD=0.12,': [117], '-1.25-1.49);': [120], 'there': [121, 147], 'was': [122, 148], 'no': [123, 149], 'differences': [124, 150], 'overall': [126], 'withdrawals': [127, 133], '(RR=1.11,': [128], '0.95-1.31),': [131], 'or': [132], 'due': [134], 'adverse': [136, 155, 163], 'events': [137, 156], '(RR=1.14,': [138], '0.90-1.45)': [141], 'between': [142], 'two': [144], 'formulations;': [145], 'risks': [153], '(RR=1.02,': [157], '0.97-1.07)': [160], 'serious': [162], 'event': [164], '(RR=0.96,': [165], '0.73-1.26).\r\n\r\n\r\nConclusion\r\nOur': [168], 'shows': [170], 'are': [174], 'disease.\r\n\r\n\r\nKey': [189], 'words:': [190], '\r\nParkinson′s': [191], 'disease;\xa0Extended': [192], 'release': [193], 'pramipexole;\xa0Ropinirole': [194], 'prolonged': [195], 'release;\xa0Rotigotine': [196], 'transdermal': [197], 'patch;\xa0Systematic': [198], 'review;\xa0Non-ergot': [199], 'agonist': [201]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W3030897071', 'counts_by_year': [], 'updated_date': '2024-12-26T02:06:46.286753', 'created_date': '2020-06-05'}